Effects of aripiprazole, olanzapine, and haloperidol in a model of cognitive deficit of schizophrenia in rats: relationship with glutamate release in the medial prefrontal cortex

Antagonism at serotonin 5-HT2A receptors modulates functional activity of frontohippocampal circuit

(2010) Alessandro Gozzi et al.   PSYCHOPHARMACOLOGY

Improvement of phencyclidine-induced social behaviour deficits in rats: Involvement of 5-HT1A receptors

(2008) Shikha Snigdha et al.   BEHAVIOURAL BRAIN RESEARCH

Validation of a rat in vivo [3H]M100907 binding assay to determine a translatable measure of 5-HT2A receptor occupancy

(2008) Christopher S. Knauer et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

The antipsychotics clozapine and olanzapine increase plasma glucose and corticosterone levels in rats: Comparison with aripiprazole, ziprasidone, bifeprunox and F15063

(2008) Marie-Bernadette Assié et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Role of different monoamine receptors controlling MK-801-induced release of serotonin and glutamate in the medial prefrontal cortex: relevance for antipsychotic action

(2008) Xavier López-Gil et al.   INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY

Endogenous serotonin and serotonin2Creceptors are involved in the ability of M100907 to suppress cortical glutamate release induced by NMDA receptor blockade

(2008) Eleonora Calcagno et al.   JOURNAL OF NEUROCHEMISTRY

Aripiprazole ameliorates phencyclidine-induced impairment of recognition memory through dopamine D1 and serotonin 5-HT1A receptors

(2008) Taku Nagai et al.   PSYCHOPHARMACOLOGY

Aripiprazole and its human metabolite OPC14857 reduce, through a presynaptic mechanism, glutamate release in rat prefrontal cortex: Possible relevance to neuroprotective interventions in schizophrenia

(2008) Tsung-Tsair Yang et al.   SYNAPSE